329 related articles for article (PubMed ID: 11083677)
1. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group.
Casaburi R; Briggs DD; Donohue JF; Serby CW; Menjoge SS; Witek TJ
Chest; 2000 Nov; 118(5):1294-302. PubMed ID: 11083677
[TBL] [Abstract][Full Text] [Related]
2. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
3. Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease.
Littner MR; Ilowite JS; Tashkin DP; Friedman M; Serby CW; Menjoge SS; Witek TJ
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1136-42. PubMed ID: 10764302
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group.
van Noord JA; Bantje TA; Eland ME; Korducki L; Cornelissen PJ
Thorax; 2000 Apr; 55(4):289-94. PubMed ID: 10722768
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses.
Tashkin D; Kesten S
Chest; 2003 May; 123(5):1441-9. PubMed ID: 12740259
[TBL] [Abstract][Full Text] [Related]
6. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.
Casaburi R; Mahler DA; Jones PW; Wanner A; San PG; ZuWallack RL; Menjoge SS; Serby CW; Witek T
Eur Respir J; 2002 Feb; 19(2):217-24. PubMed ID: 11866001
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.
Hanania NA; Boota A; Kerwin E; Tomlinson L; Denis-Mize K
Drugs; 2009 Jun; 69(9):1205-16. PubMed ID: 19537837
[TBL] [Abstract][Full Text] [Related]
8. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease.
Calverley PM; Lee A; Towse L; van Noord J; Witek TJ; Kelsen S
Thorax; 2003 Oct; 58(10):855-60. PubMed ID: 14514937
[TBL] [Abstract][Full Text] [Related]
9. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes.
Celli B; ZuWallack R; Wang S; Kesten S
Chest; 2003 Nov; 124(5):1743-8. PubMed ID: 14605043
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patients.
Beier J; van Noord J; Deans A; Brooks J; Maden C; Baggen S; Mehta R; Cahn A
Int J Chron Obstruct Pulmon Dis; 2012; 7():153-64. PubMed ID: 22419863
[TBL] [Abstract][Full Text] [Related]
11. Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.
Hodder R; Kesten S; Menjoge S; Viel K
Int J Chron Obstruct Pulmon Dis; 2007; 2(2):157-67. PubMed ID: 18044688
[TBL] [Abstract][Full Text] [Related]
12. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease.
van Noord JA; Smeets JJ; Custers FL; Korducki L; Cornelissen PJ
Eur Respir J; 2002 Apr; 19(4):639-44. PubMed ID: 11998992
[TBL] [Abstract][Full Text] [Related]
14. Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging study.
Vogelberg C; Engel M; Moroni-Zentgraf P; Leonaviciute-Klimantaviciene M; Sigmund R; Downie J; Nething K; Vevere V; Vandewalker M
Respir Med; 2014 Sep; 108(9):1268-76. PubMed ID: 25081651
[TBL] [Abstract][Full Text] [Related]
15. [The efficacy and safety of low-dose tiotropium bromide inhaled via Respimat® in patients with chronic obstructive pulmonary disease].
Ma J; Zhou Z; Tang Y; Zhong N
Zhonghua Nei Ke Za Zhi; 2014 Dec; 53(12):964-8. PubMed ID: 25623564
[TBL] [Abstract][Full Text] [Related]
16. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.
Donohue JF; van Noord JA; Bateman ED; Langley SJ; Lee A; Witek TJ; Kesten S; Towse L
Chest; 2002 Jul; 122(1):47-55. PubMed ID: 12114338
[TBL] [Abstract][Full Text] [Related]
17. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of aclidinium bromide compared with placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease: results from a 6-week, randomized, controlled Phase IIIb study.
Beier J; Kirsten AM; Mróz R; Segarra R; Chuecos F; Caracta C; Gil EG
COPD; 2013 Aug; 10(4):511-22. PubMed ID: 23819698
[TBL] [Abstract][Full Text] [Related]
19. Tiotropium versus placebo for chronic obstructive pulmonary disease.
Karner C; Chong J; Poole P
Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
[TBL] [Abstract][Full Text] [Related]
20. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]